We are live on ! Find out more
DMRA

Damora Therapeutics, Inc. Ordinary Shares
DMRA

65 hedge funds and large institutions have $1.45B invested in Damora Therapeutics, Inc. Ordinary Shares in 2026 Q1 according to their latest regulatory filings, with 51 funds opening new positions, 13 increasing their positions, 0 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,116% more capital invested

Capital invested by funds: $65.5M → $1.45B (+$1.39B)

1,600% more first-time investments, than exits

New positions opened: 51 | Existing positions closed: 3

400% more funds holding in top 10

Funds holding in top 10: 1 → 5 (+4)

261% more funds holding

Funds holding: 18 → 65 (+47)

23.41% more ownership

Funds ownership: 69.45% → 92.86% (+23%)

Holders
65
Holders Change
+47
Holders Change %
+261.11%
% of All Funds
0.8%
Holding in Top 10
5
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+400%
% of All Funds
0.06%
New
51
Increased
13
Reduced
–
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$226M
2
FFM
Fairmount Funds Management
Pennsylvania
+$224M
3
ACA
Avoro Capital Advisors
New York
+$97.2M
4
VA
VR Adviser
New York
+$92.6M
5
FIS
FCPM III Services
Netherlands
+$62.7M

Top Sellers

Rank Fund Capital Flow
1
JG
Jain Global
New York
-$2.77M
2
SPC
Sigma Planning Corp
Michigan
-$334K
3
SWM
SHP Wealth Management
Massachusetts
-$575
Name Holding Trade Value Shares
Change 		Change in
Stake
Jane Street
51
Jane Street
New York
$296K +$294K +11,420 New
Citigroup
52
Citigroup
New York
$287K +$256K +9,968 +884%
SSA
53
Schonfeld Strategic Advisors
New York
$280K +$278K +10,824 New
Susquehanna International Group
54
Susquehanna International Group
Pennsylvania
$253K +$251K +9,770 New
XT
55
XTX Topco
Cayman Islands
$252K +$250K +9,728 New
CGIM
56
Cannon Global Investment Management
Florida
$241K +$239K +9,300 New
YIH
57
Y-Intercept (HK)
Hong Kong
$205K +$204K +7,921 New
VGA
58
Vanguard Global Advisers
Pennsylvania
$162K +$161K +6,263 New
BNP Paribas Financial Markets
59
BNP Paribas Financial Markets
France
$160K +$159K +6,194 New
PAP
60
Persistent Asset Partners
Hong Kong
$138K +$137K +5,338 New
TRCT
61
Tower Research Capital (TRC)
New York
$36.7K +$31.9K +1,242 +706%
Mirae Asset Global ETFs Holdings
62
Mirae Asset Global ETFs Holdings
Hong Kong
$8.57K +$9.07K +353 New
HI
63
Harbour Investments
Wisconsin
$1.04K +$1.03K +40 New
SS
64
SBI Securities
Japan
$363 – – –
JG
65
Jain Global
New York
– -$2.77M -120,566 Closed
SPC
66
Sigma Planning Corp
Michigan
– -$334K -14,500 Closed
SWM
67
SHP Wealth Management
Massachusetts
– -$575 -25 Closed
Royal Bank of Canada
68
Royal Bank of Canada
Ontario, Canada
– +$180 +7 New
1 2
3

DMRA Hedge Fund Activity: Q1 2026 in Review

65 of the 8,128 institutional investors tracked by Wall St. Rank reported a position in Damora Therapeutics, Inc. Ordinary Shares (DMRA) for Q1 2026, worth a combined $1.45B — up 2,116% from $65.5M a quarter earlier.

Buyers outnumbered sellers: 51 funds opened new DMRA positions and 3 closed out — a net gain of 48 holders — while 13 added to existing stakes and 0 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $226M. The largest seller was Jain Global, exiting entirely with an estimated $2.77M sold.

  • 65 institutional investors held Damora Therapeutics, Inc. Ordinary Shares (DMRA) as of Q1 2026, up from 18 in Q4 2025.
  • Funds reported $1.45B of Damora Therapeutics, Inc. Ordinary Shares stock for Q1 2026, up 2,116% quarter-over-quarter.
  • 51 funds opened new Damora Therapeutics, Inc. Ordinary Shares positions in Q1 2026 and 3 closed out, a net change of +48 holders.
  • The largest Damora Therapeutics, Inc. Ordinary Shares buyer in Q1 2026 was Fidelity Investments, an estimated $226M added.
  • The largest Damora Therapeutics, Inc. Ordinary Shares seller in Q1 2026 was Jain Global, an estimated $2.77M sold.

Based on aggregated 13F filings for Q1 2026.